Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Discordant genotype-phenotype correlation in familial hyperaldosteronism type III with KCNJ5 gene mutation: a patient report and review of the literature.
Horm Res Paediatr. 2014;82(2):138-42. doi: 10.1159/000358197. Epub 2014 May 10.
Horm Res Paediatr. 2014.
PMID: 24819081
Review.
BACKGROUND: Familial hyperaldosteronism type III (FH-III) is a rare autosomal dominant disease for which five missense mutations in KCNJ5 have been identified. ...Thereafter, spironolactone treatment successfully ameliorated hyperaldosteronism for 7 ye …
BACKGROUND: Familial hyperaldosteronism type III (FH-III) is a rare autosomal dominant disease for which five mi …
Cushing Syndrome in a Pediatric Patient With a KCNJ5 Variant and Successful Treatment With Low-dose Ketoconazole.
Tatsi C, Maria AG, Malloy C, Lin L, London E, Settas N, Flippo C, Keil M, Hannah-Shmouni F, Hoffman DA, Stratakis CA.
Tatsi C, et al.
J Clin Endocrinol Metab. 2021 May 13;106(6):1606-1616. doi: 10.1210/clinem/dgab118.
J Clin Endocrinol Metab. 2021.
PMID: 33630995
Free PMC article.
CONTEXT: Pathogenic variants in KCNJ5, encoding the GIRK4 (Kir3.4) potassium channel, have been implicated in the pathogenesis of familial hyperaldosteronism type-III (FH-III) and sporadic primary aldosteronism (PA). ...
CONTEXT: Pathogenic variants in KCNJ5, encoding the GIRK4 (Kir3.4) potassium channel, have been implicated in the pathogenesis of familia …
Item in Clipboard
Cite
Cite